| Mr Justin Gill, ARNP | |
|
2322 141st St Nw, Marysville, WA 98271-8163 | |
| (360) 441-7489 | |
| Not Available |
| Full Name | Mr Justin Gill |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 2322 141st St Nw, Marysville, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174903603 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | AP60570006 (Washington) | Primary |
| 363LF0000X | Nurse Practitioner - Family | AP60570006 (Washington) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Regional Medical Center Everett | Everett, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services- Washington | 8325100480 | 420 |
News Archive
This week PLoS Medicine publishes the third in a four-part series of policy papers examining the ways in which global health institutions and arrangements are changing and evolving.
Researchers studying a DNA-cutting enzyme with a crucial role in regulating the structure of genes have discovered a broad role for its cutting activity in driving abnormal genetic rearrangements called translocations that cause cancer, including leukemias and solid tumors.
Following the recent Coronavirus outbreak, almost three million people have been infected worldwide, whereas the death toll has already passed the 200,000 mark, according to official reports.
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
› Verified 2 days ago
| Entity Name | Public Hospital Dist No 1 Skagit |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023332749 PECOS PAC ID: 6800793522 Enrollment ID: O20040309001059 |
News Archive
This week PLoS Medicine publishes the third in a four-part series of policy papers examining the ways in which global health institutions and arrangements are changing and evolving.
Researchers studying a DNA-cutting enzyme with a crucial role in regulating the structure of genes have discovered a broad role for its cutting activity in driving abnormal genetic rearrangements called translocations that cause cancer, including leukemias and solid tumors.
Following the recent Coronavirus outbreak, almost three million people have been infected worldwide, whereas the death toll has already passed the 200,000 mark, according to official reports.
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
› Verified 2 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124270715 PECOS PAC ID: 8325100480 Enrollment ID: O20081224000111 |
News Archive
This week PLoS Medicine publishes the third in a four-part series of policy papers examining the ways in which global health institutions and arrangements are changing and evolving.
Researchers studying a DNA-cutting enzyme with a crucial role in regulating the structure of genes have discovered a broad role for its cutting activity in driving abnormal genetic rearrangements called translocations that cause cancer, including leukemias and solid tumors.
Following the recent Coronavirus outbreak, almost three million people have been infected worldwide, whereas the death toll has already passed the 200,000 mark, according to official reports.
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
› Verified 2 days ago
| Entity Name | Express Care Wa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821554452 PECOS PAC ID: 6800128067 Enrollment ID: O20200221002370 |
News Archive
This week PLoS Medicine publishes the third in a four-part series of policy papers examining the ways in which global health institutions and arrangements are changing and evolving.
Researchers studying a DNA-cutting enzyme with a crucial role in regulating the structure of genes have discovered a broad role for its cutting activity in driving abnormal genetic rearrangements called translocations that cause cancer, including leukemias and solid tumors.
Following the recent Coronavirus outbreak, almost three million people have been infected worldwide, whereas the death toll has already passed the 200,000 mark, according to official reports.
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Justin Gill, ARNP 2322 141st St Nw, Marysville, WA 98271-8163 Ph: (360) 441-7489 | Mr Justin Gill, ARNP 2322 141st St Nw, Marysville, WA 98271-8163 Ph: (360) 441-7489 |
News Archive
This week PLoS Medicine publishes the third in a four-part series of policy papers examining the ways in which global health institutions and arrangements are changing and evolving.
Researchers studying a DNA-cutting enzyme with a crucial role in regulating the structure of genes have discovered a broad role for its cutting activity in driving abnormal genetic rearrangements called translocations that cause cancer, including leukemias and solid tumors.
Following the recent Coronavirus outbreak, almost three million people have been infected worldwide, whereas the death toll has already passed the 200,000 mark, according to official reports.
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
› Verified 2 days ago
Mrs. Janet Amenisomi Oladipo, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3955 156th St Ne, Marysville, WA 98271 Phone: 254-939-2100 | |
Dorothy Colleen Todd, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4420 76th St Ne, Marysville, WA 98270 Phone: 360-304-8489 Fax: 425-304-8849 | |
Teshome Shikesso, NP PSYCH/MENTAL HEAL Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3955 156th St Ne, Marysville, WA 98271 Phone: 360-651-6400 | |
Mary Reckard, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4420 76th St Ne, Marysville, WA 98270 Phone: 360-651-7406 | |
Mrs. Karen Bloom, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1630 Grove St, Marysville, WA 98270 Phone: 360-653-3500 Fax: 360-657-3268 | |
Jesseca Wang Eskander, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4404 80th St Ne, Marysville, WA 98270 Phone: 360-659-1231 |